Address correspondence to Dr Namita Goyal, UC Irvine-MDA ALS and Neuromuscular Center, 200 S Manchester Ave, Ste 110, Orange, CA 92868, [email protected].
RELATIONSHIP DISCLOSURE: Dr Goyal has received personal compensation in the range of $500 to $4999 for serving on a scientific advisory or data safety monitoring board or on a speakers bureau for Abcuro, Alexion Pharmaceuticals, Annexon, argenx, AstraZeneca, CSL Behring, Kezar Life Sciences, Sanofi, and UCB. The institution of Dr Goyal has received research support from Alexion Pharmaceuticals, Amylyx, Anelixis Pharmaceuticals, Annexon, BrainStorm Cell Therapeutics, Cytokinetics, Fulcrum Therapeutics, the HEALEY ALS Platform Trial, Kezar Life Sciences, MediciNova, Mitsubishi Tanabe Pharma, and Transposon Therapeutics. Dr Goyal has received publishing royalties from a publication relating to health care.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Dr Goyal reports no disclosure.